Daiwa Health Development Inc. (DHD USA), our US affiliate, participated in the “Integrative Healthcare Symposium” from February 17th through 19th 2022. The symposium was held to provide healthcare professionals with the latest information on integrative medicine, at the Hilton Hotel New York (USA).

It was the first time in two years since the spread of the COVID-19. Although the number of participants was smaller than before, about 120 companies exhibited and 1,000 medical professionals visited. This time, Dr. Fred Pescatore (USA) gave a presentation on NKCP titled “Bacillopeptidase F Proprietary Blend (BFPB) and It’s Role in Metabolic Disorders”, which attracted a great deal of interest. We had a lively question and answer session after the presentation.

Daiwa will continue to expand its market in the US.